Sort
82,697 grants matching “vaccine development”
Consortium for Immunotherapeutics Against Viral Hemorrhagic Fevers
$6,522,487Erica Ollmann Saphire · Scripps Research Institute, The · U19 · FY2016 · AI
Infectious Diseases Research Technologies Core - RML
$6,518,843Robert Hohman · National Institute Of Allergy And Infectious Diseases · ZIC · FY2016 · AI
Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA
$6,509,799Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Core B - Facility Maintenance and Operation Core
$6,509,093Thomas Gary Ksiazek · University Of Texas Med Br Galveston · UC7 · FY2022 · AI
Technologies to Advance Next Generation Anthrax Vaccines
$6,501,809Howard Tranrer · Uk Health Security Agency · N01 · FY2012 · AI
Medical Oncology Fellowship Program
$6,492,409Antonio Fojo · Division Of Basic Sciences - Nci · ZIE · FY2011 · CA
Alphavirus Replicon Vaccines against Influenza
$6,490,848Alphavax Human Vaccines, Inc. · UC1 · FY2005 · AI
Transforming Clinical and Translational Research and Education at Rockefeller
$6,486,140Barry Coller · Rockefeller University · UL1 · FY2006 · RR
HIV/AIDS Vaccine Development
$6,479,016John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
HIV/AIDS Vaccine Development
$6,479,016John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
HIV/AIDS Vaccine Development
$6,479,015John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
HIV/AIDS Vaccine Development
$6,479,015Gary J Nabel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Rocky Mountain Regional Center of Excellence or Biodefense and Emerging Infectiou
$6,477,538John T Belisle · Colorado State University · U54 · FY2013 · AI
REGIONAL PRIMATE RESEARCH CENTER SUPPORT
$6,470,971University Of Wisconsin Madison · P51 · FY2000 · RR
HIV Vaccine Trials Network Laboratory Center
$6,451,056Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2025 · AI
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
$6,450,971Gregory A. Poland · Mayo Clinic Rochester · U01 · FY2011 · AI
DCTD Biopharmaceutical Development
$6,449,441David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2016 · CA
Core B - Facility Maintenance and Operation Core
$6,438,592Thomas Gary Ksiazek · University Of Texas Med Br Galveston · UC7 · FY2023 · AI
DEVELOPMENT OF A RECOMBINANT VACCINE FOR RICIN TOXIN
$6,433,316Soligenix, Inc. · UC1 · FY2004 · AI
Project 2 - GMP Manufacturing of mRNA Immunogens
$6,432,773Thomas N Denny · Duke University · U19 · FY2022 · AI
Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA
$6,432,150Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF ECD-IG PROTEIN
$6,431,145Thomas Vancott · Advanced Bioscience Laboratories, Inc. · N01 · FY2015 · AI
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH ACTIVITIES
$6,428,100Scott Hensley · University Of Pennsylvania · N01 · FY2023 · AI
Broad neutralization of pandemic threat coronaviruses
$6,423,268Paul D Bieniasz · Rockefeller University · P01 · FY2022 · AI
VACCINE TECHNOLOGIES TO ADVANCE NEXT GENERATION ANTHRAX VACCINES
$6,412,369Howard Tranter · · N01 · FY2017 · AI